Kolaja Carey OConnor

CIK 00018487171 companyNASHVILLE, TN

Transactions

Companies

Filings

CIK

0001848717

Recent Transactions

16 trades

Disposition to Issuer
Revance Therapeutics, Inc.
Common Stock
2025-02-06−15,000→ 0 total
Disposition from Tender
Revance Therapeutics, Inc.
Common Stock
2025-02-04$3.65/sh−16,561→ 15,000 total
Award
Revance Therapeutics, Inc.
Common Stock
2024-05-01+15,000→ 31,561 total
Award
Revance Therapeutics, Inc.
Stock Option (Right to buy)
2024-05-01+23,458→ 23,458 total
Exercise/Conversion
Revance Therapeutics, Inc.
Stock Option (Right to buy)
2023-06-15−2,500→ 8,256 total
Sale
Revance Therapeutics, Inc.
Common Stock
2023-06-15$28.24/sh−2,500→ 16,561 total
Exercise/Conversion
Revance Therapeutics, Inc.
Common Stock
2023-06-15$18.12/sh+2,500→ 19,061 total
Award
Revance Therapeutics, Inc.
Stock Option (Right to buy)
2023-05-03+5,915→ 5,915 total
Award
Revance Therapeutics, Inc.
Common Stock
2023-05-03+3,534→ 16,561 total
Award
Revance Therapeutics, Inc.
Stock Option (Right to buy)
2022-05-04+10,756→ 10,756 total
Award
Revance Therapeutics, Inc.
Common Stock
2022-05-04+6,059→ 13,027 total
Award
Revance Therapeutics, Inc.
Stock Option (Right to buy)
2022-05-04+11,343→ 11,343 total
Award
Revance Therapeutics, Inc.
Stock Option (Right to buy)
2021-05-05+1,268→ 1,268 total
Award
Revance Therapeutics, Inc.
Common Stock
2021-05-05+674→ 6,968 total
Award
Revance Therapeutics, Inc.
Common Stock
2021-03-01+6,294→ 6,294 total
Award
Revance Therapeutics, Inc.
Stock Option (Right to buy)
2021-03-01+11,417→ 11,417 total

C/O REVANCE THERAPEUTICS, INC. 1222 DEMONBREUN STREET, 20TH FLOOR

NASHVILLE, TN, 37203